| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0733-8635(02)00027-X |
| P698 | PubMed publication ID | 12380052 |
| P2093 | author name string | Gary S Rogers | |
| Stephanie M Braun | |||
| P2860 | cites work | Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial | Q24530611 |
| Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma | Q24540048 | ||
| TRP-PLIK, a bifunctional protein with kinase and ion channel activities | Q28143098 | ||
| Prognosis of thick cutaneous melanoma | Q33538349 | ||
| High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. | Q33905836 | ||
| Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. | Q34010098 | ||
| Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system | Q34086787 | ||
| Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma | Q34086791 | ||
| Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. | Q34309669 | ||
| Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. | Q34371245 | ||
| Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system | Q34418926 | ||
| Model predicting survival in stage I melanoma based on tumor progression | Q34669608 | ||
| Influence of gender on survival in patients with stage I malignant melanoma | Q36004926 | ||
| Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation | Q36079912 | ||
| Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma | Q36114813 | ||
| Effect of initial biopsy procedure on prognosis in Stage 1 invasive cutaneous malignant melanoma: review of 1086 patients | Q37426818 | ||
| Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic | Q37521168 | ||
| Histology and prognosis in malignant melanoma | Q71261875 | ||
| The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas | Q71275943 | ||
| "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness | Q71293134 | ||
| Prognosis of skin melanoma with regional node metastases (stage II) | Q71331841 | ||
| Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger | Q71545789 | ||
| Regression in malignant melanoma | Q71688574 | ||
| Biologic behavior of thin malignant melanomas with regressive changes | Q71726901 | ||
| Metastasis and death in patients with thin melanomas (less than 0.76 mm) | Q71758292 | ||
| Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis | Q71767718 | ||
| MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas | Q71893627 | ||
| Acral lentiginous melanoma. A histological type without prognostic significance | Q72352686 | ||
| Prognostic factors in thin cutaneous malignant melanoma | Q72386102 | ||
| Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden | Q72390364 | ||
| Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome | Q72526940 | ||
| Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis | Q72559262 | ||
| Skin melanoma. Cured fraction and survival time as functions of thickness, site, histologic type, age, and sex | Q72851724 | ||
| Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma | Q72871412 | ||
| Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis | Q73021255 | ||
| S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma | Q73181527 | ||
| Utility of tests for circulating melanoma cells in identifying patients who develop recurrent melanoma | Q73225331 | ||
| Melastatin expression and prognosis in cutaneous malignant melanoma | Q73513603 | ||
| The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group | Q73615764 | ||
| Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial | Q73668810 | ||
| Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma | Q74081681 | ||
| Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma | Q74705623 | ||
| Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes | Q77788719 | ||
| Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin | Q77993448 | ||
| Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator | Q93589848 | ||
| Prognostic histopathological factors in malignant melanoma | Q93622036 | ||
| Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients | Q94999644 | ||
| Prognostic factors in thin cutaneous malignant melanoma | Q37924124 | ||
| Acral melanoma: a review of 185 patients with identification of prognostic variables | Q37965515 | ||
| Prognostic factors for survival of patients treated systemically for disseminated melanoma. | Q38529290 | ||
| Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease | Q38535120 | ||
| Age as a prognostic factor in the malignant melanoma population | Q38572034 | ||
| Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients | Q39616273 | ||
| Lethal "thin" malignant melanoma. Identifying patients at risk | Q39714283 | ||
| Prognosis for recurrent stage I malignant melanoma | Q39784979 | ||
| Prognostic factors for stage I melanoma of the skin: a review | Q39863065 | ||
| Ulceration and prognosis in cutaneous malignant melanoma | Q40343842 | ||
| Classification of malignant melanomas according to the histologic morphology of melanoma nodules | Q40347714 | ||
| Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group | Q40646286 | ||
| Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials | Q40738758 | ||
| Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience | Q40757470 | ||
| Prognostic variables for patients with stage III malignant melanoma | Q40770556 | ||
| Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients | Q40821958 | ||
| Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma | Q40844473 | ||
| Thin melanomas with unusual aggressive behavior: a report on nine cases. Melanoma Group of French Federation of Cancer Centers | Q40975458 | ||
| Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience | Q41459531 | ||
| The regressing thin malignant melanoma: a distinctive lesion with metastatic potential | Q43877987 | ||
| Application of multistage Markov modeling to malignant melanoma progression | Q44097442 | ||
| The prognostic significance of ulceration of cutaneous melanoma | Q44362550 | ||
| Cutaneous melanoma: prognosis and treatment results worldwide | Q44432993 | ||
| A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models | Q44799666 | ||
| Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck | Q44825049 | ||
| A new American Joint Committee on Cancer staging system for cutaneous melanoma | Q44869575 | ||
| The prognostic implications of location for scalp melanoma | Q45819354 | ||
| Prognostic value of size of lymph node metastases in patients with cutaneous melanoma | Q47348250 | ||
| Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction | Q47684470 | ||
| Sentinel node biopsies in melanoma patients: a protocol for accurate, efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR. | Q50514150 | ||
| A long-term analysis of 620 patients with malignant melanoma at a major referral center. | Q50861630 | ||
| A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods | Q52437315 | ||
| A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. | Q52735595 | ||
| Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma. | Q52864238 | ||
| Observer variation in histological classification of cutaneous malignant melanoma. | Q52877110 | ||
| Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. | Q52887726 | ||
| Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. | Q52905241 | ||
| The prognosis of patients with stage III melanoma. Prospective long-term study of 286 patients of the Fachklinik Hornheide. | Q53390864 | ||
| Kl 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters | Q53497293 | ||
| Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study. | Q53934608 | ||
| Regression in malignant melanoma. A histologic feature without independent prognostic significance. | Q54617196 | ||
| Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. | Q55062905 | ||
| Molecular staging of malignant melanoma: correlation with clinical outcome | Q58748254 | ||
| Proliferating cell nuclear antigen (PCNA) and recurrence in patients with cutaneous melanoma | Q62711497 | ||
| Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression | Q63977902 | ||
| Tumor thickness in evaluating prognosis of cutaneous melanoma | Q67324351 | ||
| Tumor Thickness, Level of Invasion and Node Dissection in Stage I Cutaneous Melanoma | Q67336501 | ||
| Prognostic index in malignant melanoma | Q67349831 | ||
| Problems in the measurement of tumor thickness and level of invasion in cutaneous melanoma | Q67556349 | ||
| The Prognostic Implications of Microscopic Satellites in Patients With Clinical Stage I Melanoma | Q67909100 | ||
| Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981 | Q68003754 | ||
| Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis | Q68060950 | ||
| Prognostic significance of proliferation and motility in primary malignant melanoma of the skin | Q68142169 | ||
| The prognostic significance of histologic regression in cutaneous melanoma | Q68233772 | ||
| Plasma cells within the infiltrate of primary cutaneous malignant melanoma of the skin. A confirmation of its histoprognostic value | Q68694664 | ||
| Axillary dissection in melanoma. Prognostic variables in node-positive patients | Q68864789 | ||
| Thickness of malignant melanoma: global analysis of related factors | Q68964129 | ||
| Thin malignant melanomas with regression and metastases | Q69415764 | ||
| Thin malignant melanomas and recurrence potential | Q69416099 | ||
| Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype | Q69418979 | ||
| Sex differences in presentation of cutaneous malignant melanoma and in survival from stage I disease | Q69565877 | ||
| The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry | Q69580123 | ||
| Hazard-rate analysis in state I malignant melanoma | Q69584945 | ||
| Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases | Q69716711 | ||
| Malignant melanoma in the elderly | Q69728112 | ||
| Prognostic index for malignant melanoma | Q69745517 | ||
| Vascular invasion in malignant melanomas. An independent prognostic variable? | Q69951212 | ||
| Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases | Q69976922 | ||
| Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical stage I. A multivariate regression analysis | Q69976925 | ||
| Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions | Q70269701 | ||
| The female superiority in survival in clinical stage II cutaneous malignant melanoma | Q70332962 | ||
| A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia | Q70535936 | ||
| Lentigo maligna melanoma has no better prognosis than other types of melanoma | Q70592426 | ||
| Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment | Q70700834 | ||
| Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness | Q70709103 | ||
| A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II) | Q70717837 | ||
| A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease | Q70717847 | ||
| Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes | Q70755933 | ||
| A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III) | Q71186808 | ||
| Is malignant melanoma arising in a Hutchinson's melanotic freckle a separate disease entity? | Q71240108 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 647-58, viii-ix | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Dermatologic Clinics | Q15758379 |
| P1476 | title | Prognostic factors. | |
| P478 | volume | 20 |
Search more.